Alpha 2.0
Login Register
» Articles » PMID: 32731911

Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020

Overview
Journal Emerg Infect Dis
Specialty Infectious Diseases
Date 2020 Aug 1
PMID 32731911
Citations 23
Authors
Amy K Feehan
Daniel Fort
Julia Garcia-Diaz
Eboni G Price-Haywood
Cruz Velasco
Eric Sapp
Dawn Pevey
Leonardo Seoane
Affiliations
Soon will be listed here.
Abstract

Using a novel recruitment method and paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined seroprevalence in a racially diverse municipality in Louisiana, USA. Infections were highly variable by ZIP code and differed by race/ethnicity. Overall census-weighted seroprevalence was 6.9%, and the calculated infection fatality ratio was 1.63%.

Citing Articles

Call to Action for Improving Community Health While Reducing Health Disparities.

Price-Haywood E Ochsner J. 2023; 23(2):104-105.

PMID: 37323519 PMC: 10262942. DOI: 10.31486/toj.23.0040.

Demographic, social, and behavioral correlates of SARS-CoV-2 seropositivity in a representative, population-based study of Minnesota residents.

Abhold J, Wozniak A, Mulcahy J, Walsh S, Zepeda E, Demmer R PLoS One. 2023; 18(6):e0279660.

PMID: 37319239 PMC: 10270347. DOI: 10.1371/journal.pone.0279660.

Geographically skewed recruitment and COVID-19 seroprevalence estimates: a cross-sectional serosurveillance study and mathematical modelling analysis.

Brown T, de Salazar Munoz P, Bhatia A, Bunda B, Williams E, Bor D BMJ Open. 2023; 13(3):e061840.

PMID: 36882240 PMC: 10008195. DOI: 10.1136/bmjopen-2022-061840.

Leveraging CTSA hubs for rapid, large-scale, high-impact research: A case study during a global public health emergency.

Croker J, Valenti S, Baus H, Ford E, Mathias D, Yasko L J Clin Transl Sci. 2023; 7(1):e13.

PMID: 36755544 PMC: 9879899. DOI: 10.1017/cts.2022.484.

Low Mortality of Orthopedic Trauma Patients With Asymptomatic COVID-19: A Level I Trauma Center Pandemic Experience.

Massey P, Andre L, Kautz S, Lobrano C, Barton R, Perry K Ochsner J. 2022; 22(3):204-210.

PMID: 36189099 PMC: 9477134. DOI: 10.31486/toj.21.0117.

References
1.
Wilson N, Kvalsvig A, Telfar Barnard L, Baker M . Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality. Emerg Infect Dis. 2020; 26(6):1339-1441. PMC: 7258483. DOI: 10.3201/eid2606.200320. View
2.
Bryan A, Pepper G, Wener M, Fink S, Morishima C, Chaudhary A . Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho. J Clin Microbiol. 2020; 58(8). PMC: 7383515. DOI: 10.1128/JCM.00941-20. View
3.
Price-Haywood E, Burton J, Fort D, Seoane L . Hospitalization and Mortality among Black Patients and White Patients with Covid-19. N Engl J Med. 2020; 382(26):2534-2543. PMC: 7269015. DOI: 10.1056/NEJMsa2011686. View
4.
Pollan M, Perez-Gomez B, Pastor-Barriuso R, Oteo J, Hernan M, Perez-Olmeda M . Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020; 396(10250):535-544. PMC: 7336131. DOI: 10.1016/S0140-6736(20)31483-5. View